Search for Clinical Trial Results

Sponsored By

Chikungunya - 2 Studies Found

Status Study
RECRUITING Study Name: Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination
Condition: Chikungunya Virus Infection
Date: 2025-01-16
Interventions: PXVX0317 vaccine is comprised of chikungunya virus virus-like particles (CHIKV VLP) 40mg, aluminum hydroxide 2% adjuvant, and formulation buffer suppl
COMPLETED Study Name: Phase 1 Study of SAR440894 vs Placebo
Condition: Chikungunya Virus Infection
Date: 2025-01-16
Interventions: One time 60-minute IV infusion of lyophilized placebo for SAR440894